- Patent Title: Controlled release oral pharmaceutical dosage forms comprising MGBG
-
Application No.: US15583697Application Date: 2017-05-01
-
Publication No.: US10881626B2Publication Date: 2021-01-05
- Inventor: John McKearn , Jeremy Blitzer
- Applicant: Pathologica LLC
- Applicant Address: US CA San Francisco
- Assignee: Pathologica LLC
- Current Assignee: Pathologica LLC
- Current Assignee Address: US CA San Francisco
- Agent Dennis A. Bennett; Cynthia Hathaway; Clifford A. Schlecht
- Main IPC: A61K31/155
- IPC: A61K31/155 ; A61K9/48 ; A61K9/28 ; A61K9/50 ; A61K9/20 ; C07C251/12 ; C07C251/78 ; C07C243/16 ; C07C211/13
Abstract:
Disclosed herein are controlled-release oral pharmaceutical dosage forms comprising MGBG, and their application for the improved treatment of diseases with reduced side effects and/or longer time at maximum concentration.
Public/Granted literature
- US20180050000A1 CONTROLLED RELEASE ORAL PHARMACEUTICAL DOSAGE FORMS COMPRISING MGBG Public/Granted day:2018-02-22
Information query
